Page March 2 2020 T H E P O S T
10
AT THE LIBRARY
From Amazon: "Mary and Sean walk readers through the process of assessing and buying stocks step-by- step. Their friendly and direct style and concrete examples make it easy to understand how to avoid common pitfalls and prosper in the stock market." Now at the public library.
USB BIKE LIGHTS
These minimalist lights attach to any bike frame with a simple elastic cord, and light up at the touch of a button. Even better? They're rechargeable. The brilliant LED bulbs make you more visible on the road and illuminate the ground around you (uncommongoods.com).
TOPPER TRIO ON-THE-GO COLANDER
The perfect bite needs a balance of texture: the crunch of a veggie, the smoothness of an avocado, a creamy dressing drizzle. This trio of vegan dry condiments will help dishes reach their full potential. Get your own pack of goodies for only $25 at uncommongoods.com. Grab fresh berries for breakfast or a cherry tomato afternoon snack with this handy to-go pot. The colander insert lets you rinse your gorgeous fruit or veggies on the spot. The included stainless steel fork makes this an all-in-one produce packing solution (uncommongoods.com).
We scour the Internet every week to bring you the latest, greatest tech toys and gadgets we can find. If you have ideas for items and/or themes for future editions of "The Coolest Stuff in the World" please send them to info@postpaper.com.
CENTRE, ALABAMA
256-927-5569
Ef Expert recommendations
lzheimer's disease is a condition that leads to severe memory loss, dementia and eventual death due to loss
A
of the ability to function. Health experts indicate that the true cause of this disease is not known. Alzheimer's is associated with a lower presence of acetylcholine in the body. Acetylcholine is a neurotransmitter responsible for helping activate muscles. A proposed theory as to why Alzheimer's disease occurs is based on a buildup of proteins that are either overproduced in younger individuals or removed slower in older individuals. Aging and the loss of brain cells are also factors that play a role. The non-controllable risk factors associated with this condition are having a family history of the disease or certain inherited genes. The most common symptoms are memory impairment, impairment of judgment and problem solving. Treatment for Alzheimer's disease includes medications known as cholinesterase inhibitors, which work by increasing the amount of acetylcholine that is present. These include tacrine, donepezil, rivastigmine and galantamine. In advanced cases, another medication called Memantine may be prescribed. Another class of medications called the antioxidants, have been used.
Alzheimer's disease
panel of investigators assembled by the National Advisory Eye Council (NAEC) calls for large-scale collaborative
A
research to address dry macular degeneration-the leading cause of blindness among the elderly-for which there is currently no effective treatment. The 12-member panel recognized the need to investigate the current state of research on this disease, in order to guide the direction in which to take future research. There are two types of age-related macular degeneration (AMD). "Wet" (neovascular) AMD, for which there are effective treatments that target limiting the inappropriate growth of new blood vessels that end up disrupting vision in the delicate tissues of the eye. "Dry" (non-neovascular) AMD is a more gradual vision loss from deposits of a substance called drusen, composed of fats and proteins. The proposed causes of dry AMD are numerous and are not all clear to the scientific and medical community. Among the ideas proposed in the article are drawing forth "integrated collaboration of leading clinicians, imaging experts, a wide variety of basic scientists, bioinformaticians and biostatisticians" as well as creating a large biorepository of eye tissue from donors with and without AMD, generating multiple types of omics data from disease and normal eye tissue, and designing computer models of the disease. "Success in these areas will likely be achieved most expediently and effectively by promoting collaborative efforts of multidisciplinary investigator teams and developing centralized resources including clinical, imaging, omic, and other types of data as well as carefully phenotyped eye tissue from large cohorts of patients with and without AMD."
Previous Page